Publications by authors named "Jacques- Eric Gottenberg"

Claim this Profile
R
Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren's Disease and Association with Patient-Reported Outcomes.
Jacques-Eric Gottenberg, Raphaele Seror, Nicola Massey, Megan Hughes, Victoria Barton

Rheumatol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial.
Alice Courties, Sophie Tuffet, Grégoire Cormier, Christian H Roux, Paul Ornetti, Jacques-Éric Gottenberg

Lancet Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel vascular damage markers in SLE: insights from carotid colour Doppler ultrasound and aortic oscillometry in the LUPCARD cohort.
Konstantinos Triantafyllias, Felix Tietze, George Bertsias, Jacques-Eric Gottenberg, Andreas Schwarting

RMD Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial.
Ghaith Noaiseh, Kathy L Sivils, Kim Campbell, Jada Idokogi, Kim Hung Lo, Jacques-Eric Gottenberg

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE.
Jacques Morel, Amélie Wetzman, Daniel Wendling, Martin Soubrier, Sylvie Hoang, Jacques-Eric Gottenberg

Joint Bone Spine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica.
Baptiste Chevet, Aghiles Souki, Emmanuel Nowak, Guillermo Carvajal-Alegria, Emmanuelle Dernis, Jacques-Eric Gottenberg

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases.
Jérôme Avouac, Olivier Fogel, Maxime Beydon, Grégoire Martin de Frémont, Gary Birsen, Jacques-Eric Gottenberg

Joint Bone Spine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.
Jacques Morel, Emmanuelle Dernis, Christian Roux, Christophe Richez, Olivier Brocq, Jacques-Eric Gottenberg

Lancet Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease.
Pierre-Antoine Juge, Marie-Pierre Debray, Valérie Devauchelle Pensec, Christophe Richez, Jérôme Avouac, Jacques-Eric Gottenberg

Joint Bone Spine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Mandi M Wiley, Marcin Radziszewski, Bhuwan Khatri, Michelle L Joachims, Kandice L Tessneer, Jacques-Eric Gottenberg

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy.
Angeliki Zoi Lignou, Konstantinos D Vassilakis, Xenofon Baraliakos, Petros P Sfikakis, Jacques-Eric Gottenberg

Autoimmun Rev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Images: Sarcoidosis revealed by recurrent dactylitis.
Thomas Subervie, Thibault Willaume, Amin Maazouzi, Jacques-Eric Gottenberg, Jean Sibilia

Arthritis Rheumatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture.
Renaud Felten, Kevin Bigaut, Thomas Wirth, Laurent Kremer, Lucas Gauer, Jacques-Eric Gottenberg

BMC Med Educ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Vasculitis in Primary Sjögren Disease.
Paul Breillat, Véronique Le Guern, Thomas d'Humières, Maxime Battistella, Paul Legendre, Jacques-Eric Gottenberg

JAMA Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data.
Yann Nguyen, Maxime Beydon, Jacques-Eric Gottenberg, Jacques Morel, Aleth Perdriger

Arthritis Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 International Rome consensus for the nomenclature of Sjögren disease.
Manuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, Katherine M Hammitt, Coralie Bouillot, Jacques Eric Gottenberg

Nat Rev Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).
Simon J Bowman, Raphaele Seror, Raphael Porcher, Suzanne Arends, Liseth de Wolff, Jacques-Eric Gottenberg

Ann Rheum Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients.
Ariane Benezech, Jacques-Eric Gottenberg, Yannick Degboé, Andrey Kruglov, Jane Grogan

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial.
Tristan Pascart, Bruno Fautrel, Jacques-Eric Gottenberg, Vincent Ducoulombier, Christophe Richez

BMJ Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, Daniel Aletaha, Johan Askling, Jacques-Eric Gottenberg

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study.
Félicien Triboulet, Pierre-Antoine Juge, Marie-Elise Truchetet, Thao Pham, Nicolas Roux, Jacques-Eric Gottenberg

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sjögren's disease on quality of sexual life using the Qualisex score.
Alexandra Kachaner, Raphaele Seror, Véronique Le Guern, Philippe Dieudé, Jacques-Eric Gottenberg

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial.
Adeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, Vanina Bongard, Carine Salliot, Jacques-Eric Gottenberg

Ann Rheum Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Kim Lauper, Juan Molina-Collada, Daniel Aletaha, Johan Askling, Jacques-Eric Gottenberg

Ann Rheum Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients.
Lucie Aubergeon, Renaud Felten, Jacques-Eric Gottenberg, Hélène Dumortier, Fanny Monneaux

Cells· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis